The spleen is the major site for the development and expansion of inhibitor producing-cells in hemophilia A mice upon FVIII infusion developing high-titer inhibitor-Reference-Cited by-同舟云学术

The spleen is the major site for the development and expansion of inhibitor producing-cells in hemophilia A mice upon FVIII infusion developing high-titer inhibitor

Published:2023-11 Issue: Volume:231 Page:144-151
ISSN:0049-3848
Container-title:Thrombosis Research
language:en
Short-container-title:Thrombosis Research

Author:

Oda Akihisa,Furukawa Shoko,Kitabatake Masahiro,Ouji-sageshima Noriko,Sonobe Shota,Horiuchi Kaoru,Nakajima Yuto,Ogiwara Kenichi,Goitsuka Ryo,Shima Midori,Ito Toshihiro,Nogami Keiji

Funder

Sanofi Kabushiki Kaisha

Ministry of Education, Culture, Sports, Science and Technology

Sanofi

Publisher

Elsevier BV

Subject

Hematology

Reference33 articles.

1. Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia;Manco-Johnson;N. Engl. J. Med.,2007

2. Factor VIII-mimetic function of humanized bispecific antibody in hemophilia A;Shima;N. Engl. J. Med.,2016

3. Prediction of the haemostatic effects of bypassing therapy using comprehensive coagulation assays in emicizumab prophylaxis-treated haemophilia a patients with inhibitors;Furukawa;Br. J. Haematol.,2020

4. The human spleen is a major reservoir for long-lived vaccinia virus-specific memory B cells;Mamani-Matsuda;Blood,2008

5. Marginal zone B cells are critical to factor VIII inhibitor formation in mice with hemophilia A;Zerra;Blood,2017

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recapitulating the immune system of hemophilia A patients with inhibitors using immunodeficient mice;Thrombosis Research;2024-03